G
Geneviève Depresseux
Researcher at Université catholique de Louvain
Publications - 30
Citations - 3085
Geneviève Depresseux is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: Bone density & Bone mineral. The author has an hindex of 19, co-authored 30 publications receiving 2837 citations. Previous affiliations of Geneviève Depresseux include Catholic University of Leuven.
Papers
More filters
Journal ArticleDOI
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Frédéric Houssiau,Carlos Vasconcelos,David D'Cruz,Gian Domenico Sebastiani,Enrique de Ramón Garrido,Maria Giovanna Danieli,Daniel Abramovicz,Daniel Engelbert Blockmans,Alessandro Mathieu,Haner Direskeneli,Mauro Galeazzi,Ahmet Gül,Yair Levy,Peter Petera,Rajko Popovic,Radmila Petrovic,Renato Alberto Sinico,Roberto Cattaneo,Josep Font,Geneviève Depresseux,Jean-Pierre Cosyns,Ricard Cervera +21 more
TL;DR: The data from the ELNT indicate that in European SLE patients with proliferative lupus nephritis, a remission-inducing regimen of low-dose IV CYC (cumulative dose 3 gm) followed by AZA achieves clinical results comparable to those obtained with a high-dose regimen.
Journal ArticleDOI
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
Frédéric Houssiau,Carlos Vasconcelos,David D'Cruz,Gian Domenico Sebastiani,E. De Ramon Garrido,Maria Giovanna Danieli,Daniel Abramovicz,Daniel Engelbert Blockmans,Alberto Cauli,Haner Direskeneli,Mauro Galeazzi,Ahmet Gül,Yair Levy,Peter Petera,Rajko Popovic,Radmila Petrovic,Renato Alberto Sinico,Roberto Cattaneo,J Font,Geneviève Depresseux,J-P Cosyns,Ricard Cervera +21 more
TL;DR: The data confirm that a LD IVCY regimen followed by AZA—the “Euro-Lupus regimen”—achieves good clinical results in the very long term.
Journal ArticleDOI
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
Frédéric Houssiau,David D'Cruz,Shirish Sangle,Philippe Remy,Carlos Vasconcelos,Radmila Petrovic,Christoph Fiehn,Enrique de Ramón Garrido,Inge-Magrethe Gilboe,Maria G Tektonidou,Daniel Engelbert Blockmans,Isabelle Ravelingien,Véronique Le Guern,Geneviève Depresseux,Loïc Guillevin,Ricard Cervera +15 more
TL;DR: Fewer renal flares were observed in patients receiving MMF but the difference did not reach statistical significance and over a 3-year period, 24 h proteinuria, serum creatinine, serum albumin, serum C3, haemoglobin and global disease activity scores improved similarly in both groups.
Journal ArticleDOI
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial
Frédéric Houssiau,Carlos Vasconcelos,David D'Cruz,Gian Domenico Sebastiani,Enrique de Ramón Garrido,Maria Giovanna Danieli,Daniel Abramovicz,Daniel Engelbert Blockmans,Alessandro Mathieu,Haner Direskeneli,Mauro Galeazzi,Ahmet Gül,Yair Levy,Peter Petera,Rajko Popovic,Radmila Petrovic,Renato Alberto Sinico,Roberto Cattaneo,Josep Font,Geneviève Depresseux,Jean-Pierre Cosyns,Ricard Cervera +21 more
TL;DR: Long-term followup of patients from the ELNT confirms that, in lupus nephritis, a remission-inducing regimen of low-dose IV CYC followed by AZA achieves clinical results comparable with those obtained with a high-dose regimen.
Journal Article
(18)F-fluoride PET for monitoring therapeutic response in Paget's disease of bone.
Johanne Installé,Adrien Nzeusseu,Anne Bol,Geneviève Depresseux,Jean-Pierre Devogelaer,Max Lonneux +5 more
TL;DR: F-18-fluoride PET can be used to noninvasively and accurately monitor the efficacy of treatment with bisphosphonates in Paget's disease of bones and correlates with Ki-PAT and Ki-NLR and, interestingly, varies in the same manner as kinetic indices.